 |
|
Cardiac arrest caused by nafamostat mesilate
Hyo Shik Kim, Kyung Eun Lee, Ji Hyun Oh, Chan Sung Jung, Dughyun Choi, Yunsuek Kim, Jin Seok Jeon, Dong Cheol Han, Hyunjin Noh
Kidney Res Clin Pract. 2016;35(3):187-189. Published online 2015 Nov 12 DOI: https://doi.org/10.1016/j.krcp.2015.10.003
|
|
Citations to this article as recorded by
 Evaluating Risk Factors for Developing Allergic Reactions during Plasma Exchange Using Fresh-frozen Plasma: A Single-center Retrospective Study
Tetsuya Abe, Togo Aoyama, Yasuo Takeuchi
Internal Medicine.2023; 62(19): 2803. CrossRef Promising Repurposed Antiviral Molecules to Combat SARS-CoV-2:
A Review
Yashumati Ratan, Aishwarya Rajput, Vivek Jain, Dinesh Kumar Mishra, Rupesh Kumar Gautam, Ashutosh Pareek
Current Pharmaceutical Biotechnology.2023; 24(14): 1727. CrossRef Anticoagulation with nafamostat mesilate during extracorporeal life support
Yuheng Lang, Yue Zheng, Bingcai Qi, Weifeng Zheng, Jin Wei, Chengxiu Zhao, Wenqing Gao, Tong Li
International Journal of Cardiology.2022; 366: 71. CrossRef Nafamostat is a Potent Human Diamine Oxidase Inhibitor Possibly Augmenting Hypersensitivity Reactions during Nafamostat Administration
Thomas Boehm, Marion Alix, Karin Petroczi, Serhii Vakal, Elisabeth Gludovacz, Nicole Borth, Tiina A. Salminen, Bernd Jilma
Journal of Pharmacology and Experimental Therapeutics.2022; 382(2): 113. CrossRef Repurposing pharmaceutical excipients as an antiviral agent against SARS-CoV-2
Manisha Malani, Prerana Salunke, Shraddha Kulkarni, Gaurav K. Jain, Afsana Sheikh, Prashant Kesharwani, Jayabalan Nirmal
Journal of Biomaterials Science, Polymer Edition.2022; 33(1): 110. CrossRef Cardiopulmonary arrest caused by nafamostat mesylate during hemodialysis
Nobuki Shioya, Nozomu Inoue, Hiroki Sato, Motoko Iwahara, Tomohiro Sato, Yuki Tsukamoto, Yuki Naito, Kohji Hazama, Yasuo Shichinohe
Clinical Case Reports.2022;[Epub] CrossRef An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) b
Ka Man Yip, Kwan Ming Lee, Tzi Bun Ng, Shujun Xu, Ken Kin Lam Yung, Shaogang Qu, Allen Ka Loon Cheung, Stephen Cho Wing Sze
Chinese Medicine.2022;[Epub] CrossRef Targeting the intestinal TMPRSS2 protease to prevent SARS-CoV-2 entry into enterocytes-prospects and challenges
Ismail Sami Mahmoud, Yazun Bashir Jarrar
Molecular Biology Reports.2021; 48(5): 4667. CrossRef Anaphylactic Reactions Caused by Nafamostat Mesylate during Hemodialysis before Surgery for Carpal Tunnel Syndrome
Yuta Nakamura, Kaoru Tada, Masashi Matsuta, Atsuro Murai, Hiroyuki Tsuchiya, Yoshihide Fujigaki
Case Reports in Nephrology.2021; 2021: 1. CrossRef Fatal anaphylaxis Due to Nafamostat Mesylate During Hemodialysis
Joo-Hee Kim, Ji Young Park, Seung Hun Jang, Jwa-Kyung Kim, Young Rim Song, Hyung Seok Lee, Sung Gyun Kim
Allergy, Asthma & Immunology Research.2021; 13(3): 517. CrossRef Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2
Salma N. Tammam, Sara El Safy, Shahenda Ramadan, Sita Arjune, Eva Krakor, Sanjay Mathur
Journal of Controlled Release.2021; 337: 258. CrossRef Therapeutically effective covalent spike protein inhibitors in treatment of SARS-CoV-2
Vikram Choudhary, Amisha Gupta, Rajesh Sharma, Hamendra Singh Parmar
Journal of Proteins and Proteomics.2021; 12(4): 257. CrossRef Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia
GeorgeZaki Ghali, MichaelGeorge Zaki Ghali
Neural Regeneration Research.2020; 15(12): 2217. CrossRef Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies
Safaa M. Kishk, Rania M. Kishk, Asmaa S. A. Yassen, Mohamed S. Nafie, Nader A. Nemr, Gamal ElMasry, Salim Al-Rejaie, Claire Simons
Molecules.2020; 25(21): 5007. CrossRef Potential Anti-COVID-19 Therapeutics that Block the Early Stage of the Viral Life Cycle: Structures, Mechanisms, and Clinical Trials
Rami A. Al-Horani, Srabani Kar, Kholoud F. Aliter
International Journal of Molecular Sciences.2020; 21(15): 5224. CrossRef Challenges in Maintaining the Hemostatic Balance in Children Undergoing Extracorporeal Membrane Oxygenation: A Systematic Literature Review
Joppe G. F. Drop, Enno D. Wildschut, Sabrina T. G. Gunput, Matthijs de Hoog, C. Heleen van Ommen
Frontiers in Pediatrics.2020;[Epub] CrossRef Use of zebrafish larvae lateral line to study protection against cisplatin-induced ototoxicity: A scoping review
Ewa Domarecka, Magda Skarzynska, Agnieszka J Szczepek, Stavros Hatzopoulos
International Journal of Immunopathology and Pharmacology.2020; 34: 205873842095955. CrossRef Targeting Crucial Host Factors of SARS-CoV-2
Anil Mathew Tharappel, Subodh Kumar Samrat, Zhong Li, Hongmin Li
ACS Infectious Diseases.2020; 6(11): 2844. CrossRef A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite
Laura-Oana Albulescu, Chunfang Xie, Stuart Ainsworth, Jaffer Alsolaiss, Edouard Crittenden, Charlotte A. Dawson, Rowan Softley, Keirah E. Bartlett, Robert A. Harrison, Jeroen Kool, Nicholas R. Casewell
Nature Communications.2020;[Epub] CrossRef Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2
Lucia Lisi, Pedro Miguel Lacal, Maria Luisa Barbaccia, Grazia Graziani
Biochemical Pharmacology.2020; 180: 114169. CrossRef Sustained severe intestinal edema after nafamostat mesilate-associated anaphylactic reaction during hemodialysis
Mitsutoshi Shindo, Susumu Ookawara, Taisuke Kitano, Hiroki Ishii, Haruhisa Miyazawa, Kiyonori Ito, Yuichiro Ueda, Keiji Hirai, Taro Hoshino, Yoshiyuki Morishita
Nefrología (English Edition).2019; 39(2): 202. CrossRef Sustained severe intestinal edema after nafamostat mesilate-associated anaphylactic reaction during hemodialysis
Mitsutoshi Shindo, Susumu Ookawara, Taisuke Kitano, Hiroki Ishii, Haruhisa Miyazawa, Kiyonori Ito, Yuichiro Ueda, Keiji Hirai, Taro Hoshino, Yoshiyuki Morishita
Nefrología.2019; 39(2): 202. CrossRef The Molecular Aspect of Antitumor Effects of Protease Inhibitor Nafamostat Mesylate and Its Role in Potential Clinical Applications
Xi Chen, Zhijie Xu, Shuangshuang Zeng, Xiang Wang, Wanli Liu, Long Qian, Jie Wei, Xue Yang, Qiuying Shen, Zhicheng Gong, Yuanliang Yan
Frontiers in Oncology.2019;[Epub] CrossRef Sustained Deterioration of Hepatic Oxygenation After Nafamostat Mesilate‐Induced Anaphylactic Shock During Hemodiafiltration
Susumu Ookawara, Kiyonori Ito, Yoshiyuki Morishita
Artificial Organs.2018; 42(6): 674. CrossRef The authors’ reply
Hyo Shik Kim, Hyunjin Noh
Kidney Research and Clinical Practice.2017; 36(1): 107. CrossRef Cardiac arrest caused by nafamostat mesilate: Kounis syndrome in the dialysis room?
Ioanna Koniari, Nicholas G. Kounis
Kidney Research and Clinical Practice.2017; 36(1): 105. CrossRef Nafamostat
Reactions Weekly.2016; 1628(1): 264. CrossRef
|